Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Recruiting · NCT06826339 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. | Diabetes Complications, Diabetic Foot, Foot Diseases, Foot Ulcer, Foot Ulcer, Diabetic, Leg Ulcer, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, Varicose Ulcer, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, ulcer disease, varicose disease, vascular disorder | Recruiting | Phase 4 | 2026-09-22 | NCT06826339 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SerenaGroup, Inc. | 13 |
| Tiger Biosciences, LLC. | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Serena Group | Monroeville | United States | 3 |